Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa

Figure 1

Representative results of the patient with retinitis pigmentosa treated with intravitreal injection of autologous bone marrow-derived lineage-negative cells: eye fundus image recorded (a) directly after injection, (b) 1 month, and (c) 12 months postinjection; globe sonography (d) directly after injection, (e) 1 month, and (f) 12 months postinjection; and multifocal electroretinography (mfERG) recordings presented as amplitudes of P1 wave with highlighted central 10° at (g) baseline, (h) 1 month, and (i) 12 months postinjection.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)